Brief: SMS Pharmaceuticals Gets Certificate of Suitability Approval For Ibuprofen
22/07/2022 11:50
July 22 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS :
* RECEIVED CEP APPROVAL FOR IBUPROFEN FROM EUROPEAN
DIRECTORATE
FOR QUALITY OF MEDICINES & HEALTHCARE
Source text for Eikon: ID:nBSE74yy74
Further company coverage: SMSP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SMS Pharmaceuticals
See all newsBrief: SMS Pharmaceuticals Ltd Q2 Consol Net Profit INR 398.5 Million
Brief: SMS Pharmaceuticals March-Quarter Consol Net Profit 327.1 Million Rupees
Brief: Sms Pharmaceuticals Says Tax Demand Reduced To 4 Million Rupees From 71.9 Million Rupees
Advisory: Alert incorrectly tagged to SMS Phramaceuticals withdrawn
Brief: SMS Pharmaceuticals Says Completion Of USFDA Inspection At Vizag Manufacturing Facility